Clinical Trial Update: A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

View source ↗

Summary

A retrospective real-world study evaluating outcomes of abemaciclib in HR-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: The Affiliated Hospital of Qingdao University | Conditions: Breast Cancer, Neoplasms | Status: NOT_YET_RECRUITING